Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
736 studies found for:    Open Studies | "Platelet Aggregation Inhibitors"
Show Display Options
Rank Status Study
1 Recruiting Study on the Registration of Coronary Heart Disease Patients Undergoing PCI
Condition: Coronary Heart Disease
Intervention: Drug: antiplatelet agents
2 Unknown  Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment
Conditions: Myocardial Infarction;   STEMI
Intervention: Genetic: CYP2C19 genotyping
3 Recruiting Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease
Conditions: Cardiovascular Diseases;   Coronary Artery Disease
Intervention:
4 Recruiting The Laboratory AntiPlatelet Efficacy and Clinical Outcome Registry
Condition: Platelet Aggregation Onhibitors
Intervention: Drug: antiplatelet drugs - P2Y12 antagonists
5 Recruiting Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study
Condition: Atrial Fibrillation
Interventions: Drug: Rivaroxaban and single antiplatelet drug (aspirin, clopidogrel or prasugrel);   Drug: Rivaroxaban
6 Unknown  Study of LC23-1306 in Healthy Male Subjects
Condition: Acute Coronary Syndrome
Interventions: Drug: LC23-1306;   Drug: placebo;   Drug: Ticagrelor
7 Recruiting Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
Conditions: Coronary Artery Disease;   Myocardial Infarction;   Heart Disease;   Vascular Disease;   Angina Pectoris;   Cardiovascular Disease;   Ischemia;   Infarction;   Embolism;   Thrombosis;   Chest Pain
Interventions: Drug: clopidogrel;   Drug: Ticagrelor or prasugrel
8 Not yet recruiting Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients
Condition: Diabetes
Intervention: Drug: Clopidogrel, Prasugrel, Ticagrelor
9 Unknown  Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay
Condition: 30 Healthy People
Intervention: Drug: Clopidogrel and proton pump inhibitors
10 Recruiting Apixaban Versus Antiplatelet Drugs or no Antithrombotic Drugs After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
Conditions: Cerebral Hemorrhage;   Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Aspirin;   Drug: Carbasalate calcium;   Drug: Clopidogrel;   Drug: Dipyridamole;   Other: No antithrombotic treatment
11 Recruiting Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents
Conditions: OGD;   Gastric Ulcer Induced by Anti-platelet Agent;   Duodenal Ulcer Induced by Anti-platelet Agent
Interventions: Procedure: Second-look OGD;   Drug: Esomeprazole
12 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
13 Recruiting Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry
Condition: Non-valvular Atrial Fibrillation
Intervention:
14 Not yet recruiting Secondary Prevention of Cardiovascular Disease in the Elderly Trial
Conditions: Myocardial Infarction;   Cardiovascular Disease
Interventions: Drug: Cardiovascular Polypill;   Drug: Treatment Prevention for Secondary CV
15 Recruiting A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion
Condition: Stroke, Acute
Interventions: Drug: Tenecteplase;   Drug: Antiplatelet treatment
16 Not yet recruiting Dental Extractions in Patients Under Dual Antiplatelet Therapy
Condition: Blood Coagulation Disorders
Interventions: Device: HemCon Dental Dressing;   Device: Oxidized Cellulose Gauze
17 Recruiting Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate
Conditions: Benign Prostatic Hyperplasia;   Prostate Cancer
Intervention:
18 Recruiting What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
Conditions: Atrial Fibrillations;   Heart Valve Prostheses;   Acute Coronary Syndromes;   Coronary Artery Diseases;   Stroke;   Bleeding;   Myocardial Infarction
Intervention: Drug: Combination of chronic oral anticoagulation and a P2Y12 inhibitor with or without aspirin.
19 Recruiting ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study
Condition: Coronary Artery Disease
Interventions: Drug: 1-month DAPT;   Drug: 12-month DAPT
20 Recruiting Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
Conditions: Arterial Occlusive Diseases;   Coronary Artery Disease;   Coronary Disease;   Arteriosclerosis;   Heart Diseases;   Myocardial Ischemia;   Vascular Diseases;   Acute Coronary Syndrome
Interventions: Drug: PZ-128;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years